Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Food, dietary supplement firms face increased litigation risk amid rise in online shopping

Litigation Daily sends Shout Out to litigation team for securing no jail time for client

Big questions addressed in conversation about crypto regulation

Schmidt and Mowbray speak at Tax Executives Institute conference

Michael’s practice focuses on patent prosecution in the biotechnology and life science fields, with a particular emphases on protein therapeutics, vaccines and gene editing technologies. A skilled laboratory scientist by training, he led research in biochemistry and molecular biology that provided invaluable insights into protein synthesis, RNA modifications and functional RNA genomics.

Michael’s numerous publications span a wide variety of topics, including protein mistranslation, enzyme substrate selectivity and kinetics, post-translational protein modifications, tRNA biology, high-throughput RNA sequencing, post-transcriptional RNA modifications&nbsp;and microbiome physiology.

core/freeform

J.D., Villanova University School of Law, 2021, 

Ph.D., Molecular Biology, The University of Chicago, 2016

B.S., Microbiology, Cornell University, 2011

Philadelphia

IP Intelligence Report

PTAB Rulings Highlight the Importance of a Claimed Agent’s Stated Function

Federal Circuit Develops the ‘At Once Envisage’ Standard of Anticipation and Affirms the Importance of Specialized Considerations in the Chemical Arts

Federal Circuit Requires Definitive Written Description Support for Quantitative Values and Ranges

Enterprise Issues

Intellectual Property

Biotechnology, Chemical, and Pharmaceutical

Michael Schwartz Ph.D.

Michael Schwartz Ph.D.

Insights and News

Prior Positions

Credentials

Areas of Focus

Enterprise Issues

Services

Featured Insights